Senior insider sale
Chief Legal Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$137.4K
11.13K shares
What this filing means
ANDERMAN TODD plans to sell 11.13K shares of OCULAR THERAPEUTIX, INC valued at approximately $137.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/8/2025ACC: 0001950047-25-007833
Officer· Chief Legal Officer
Since Oct 2024
11.13K
Shares to sell
$137.4K
Approx. market value
11.13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
10/7/2025
11.13KTotal acquired11.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/7/2025 | Restricted stock vesting under a registered plan Not Applicable | 11.13K | — |
| Total | 11.13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.13K
Market value
$137.4K
10/8/2025
Total
Units
11.13K
Value
$137.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/8/2025 | 11.13K | $137.4K | NASDAQ | Planned |
| Total | 11.13K | $137.4K | ||